The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | Causes of resistance in myeloma: loss of target and T-cell exhaustion
Paola Neri, MD, PhD, University of Calgary, Calgary, AB, Canada, briefly discusses how resistance to immunotherapies in myeloma can be caused by a loss of target and T-cell exhaustion. Dr Neri also highlights the importance of healthy memory cells and their role in patient response to therapy. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
